- Research works
- 84 ▼ 40% vs 2013–17
- Citations
- 1.6k 18.9 per fractional work
- Top-10% rate
- 18.7% record average 16.5%
- Open access
- 22% world 28%
Not ranked overall: Verastem (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.0×. Every wedge is a field page.
Who are the top researchers at Verastem (United States)?
Ranked on the composite score, David T. Weaver, Jonathan A. Pachter and Vihren N. Kolev lead among researchers whose main affiliation is Verastem (United States).
- 1 David T. Weaver United States · #266,218 worldwide 158 citations · 39 works
- 2 Jonathan A. Pachter United States · #750,836 worldwide 130 citations · 51 works
- 3 Vihren N. Kolev United States · #950,906 worldwide 25 citations · 17 works
Which keywords describe research at Verastem (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Chemotherapy, Clinical Trials, Metastasis, Immune Response, Tumor Microenvironment, Melanoma and Oncogenic Mutations.
- Tumorigenesis
- Ovarian Cancer
- Extracellular Matrix
- Biomarkers
- Breast Cancer
- Cancer Progression
- Targeted Therapy
- MAP Kinase
- Oncogenic Mutations
- Cancer
- Melanoma
- Immune Response
- Chemotherapy
- Cancer Therapy
- Clinical Trials
- Metastasis
- Tumor Microenvironment
- Cell Proliferation
- BRAF gene
- Immunotherapy
- Angiogenesis
- Inflammation
- ALK Inhibitors
- EGFR Mutations
- Genomic Analysis
- Pim Oncogenes
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Cancer Therapy3▲ 29×6 topics
- Chemotherapy3▲ 22×7 topics
- Clinical Trials2▲ 18×4 topics
- Immune Response2▲ 21×3 topics
- Metastasis2▲ 35×4 topics
- Melanoma2▲ 185×2 topics
- Tumor Microenvironment2▲ 25×5 topics
- Cancer2▲ 7.4×8 topics
- Cell Proliferation2▲ 114×2 topics
- Oncogenic Mutations2▲ 402×2 topics
- BRAF gene2▲ 591×1 topic
- MAP Kinase2▲ 591×1 topic
- Immunotherapy2▲ 11×7 topics
- Targeted Therapy2▲ 36×3 topics
- Angiogenesis2▲ 23×5 topics
- Cancer Progression2▲ 39×3 topics
- Inflammation1▲ 3.3×6 topics
- Breast Cancer1▲ 28×3 topics
- ALK Inhibitors1▲ 92×1 topic
- Biomarkers1▲ 8.9×2 topics
- EGFR Mutations1▲ 92×1 topic
- Extracellular Matrix1▲ 32×3 topics
- Genomic Analysis1▲ 21×1 topic
- Ovarian Cancer1▲ 59×1 topic
- Pim Oncogenes1▲ 278×1 topic
- Tumorigenesis1▲ 135×1 topic
Which research topics does Verastem (United States) publish most on?
By volume in 2022–2025: Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, Ovarian cancer diagnosis and treatment and Cancer Mechanisms and Therapy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Melanoma and MAPK Pathways Molecular Biology 2 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 3 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
- 4 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
- 5 Cell Adhesion Molecules Research Immunology and Allergy 1 works
- 6 Colorectal Cancer Treatments and Studies Oncology 1 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 9 Peptidase Inhibition and Analysis Oncology 0 works
- 10 Chronic Lymphocytic Leukemia Research Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Verastem (United States)'s research output changed?
Output in 2018–2022 was 40% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Needham
- Renewable Energy Systems (United States)
- Franklin W. Olin College of Engineering
- Systems Analytics (United States)
- LightLine Technologies (United States)
- Center For Social Innovation
- Justice Resource Institute
- Advantagene (United States)
- Polestar Technologies (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.